Eupraxia Pharmaceuticals (NASDAQ:EPRX – Get Free Report) announced its earnings results on Thursday. The company reported ($0.37) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.16) by ($0.21), Zacks reports. Eupraxia Pharmaceuticals Stock Down 0.9% Shares of NASDAQ EPRX opened at $7.51 on Thursday. The firm has a market cap of $270.06 […]

Eupraxia Pharmaceuticals Inc. (NASDAQ:EPRX – Get Free Report) was the target of a large increase in short interest in February. As of February 27th, there was short interest totaling 1,979,996 shares, an increase of 19.4% from the February 12th total of 1,658,534 shares. Approximately 5.5% of the shares of the stock are sold short. Based […]